Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Kidney and Urinary TractDRG 675-other-kidney-and-urinary-tract-procedures-without-cc-mcc
    Ask Trek AI about this page

    Other Kidney and Urinary Tract Procedures without CC/MCC: Inpatient Reimbursement Overview

    DRG 675 encompasses other kidney and urinary tract procedures performed without a Complication or Comorbidity or Major Complication or Comorbidity and represents lower-complexity genitourinary interventions relevant to inpatient billing. It matters for inpatient reimbursement because it establishes a payment category reflecting typical resource use for these procedures under Medicare payment systems.

    Customize your policy alerts

    Sign up for drg 675 policy alerts

    Get alerted when payer policies referencing 675 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 675 Overview

    DRG 675 covers hospital stays for patients undergoing various non-major kidney and urinary tract procedures without associated Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include diagnostic or minor therapeutic genitourinary procedures that do not require extensive resources. This Diagnosis-Related Group is important for Medicare reimbursement because it groups similar resource use and informs the prospective payment for inpatient stays. Understanding the clinical scope helps hospitals anticipate payment relative to more complex kidney and urinary tract procedure groups.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Studies evaluating minimally invasive versus open surgical approaches for non-complex kidney and urinary tract procedures (e.g., partial nephrectomy for small renal masses, ureteral reconstructive procedures) focusing on intraoperative metrics, short-term complications, and length of stay. These trials enroll adult patients admitted for elective or urgent non-complicated urinary tract surgeries without major comorbid complications, comparing recovery time, perioperative resource use, and complication rates. Findings are relevant to providers for procedure selection and to payers for understanding cost drivers and potential reductions in hospital days and readmissions for cases classified in this DRG.
    • Comparative effectiveness research assessing different perioperative care pathways (enhanced recovery after surgery protocols versus standard care) for patients undergoing kidney and urinary tract procedures without CC/MCC, measuring opioid use, time to mobilization, complication rates, and discharge disposition. These studies typically include a broad inpatient population without major complications but at risk for prolonged recovery, and may stratify by age or baseline renal function to identify subgroups who benefit most. Results inform clinicians and hospitals on best practices to shorten LOS and reduce complications, and help payers model potential savings from standardized pathways in this DRG.
    • Post-discharge outcomes and health services research tracking readmissions, outpatient complications, functional recovery, and patient-reported outcomes after index hospitalizations for other kidney and urinary tract procedures without CC/MCC. These cohort studies follow patients across the 30–90 day post-discharge period to identify predictors of readmission, outpatient resource use, and long-term renal or urinary function. Insights help providers target follow-up care to high-risk patients and enable payers to estimate downstream costs and design transitional care programs to reduce avoidable utilization for this patient group.

    Related Codes

    650-KIDNEY-TRANSPLANT-WITH-HEMODIALYSIS-WITH-MCC

    Kidney Transplant with Hemodialysis with Major Complication or Comorbidity: Inpatient Reimbursement Overview

    651-KIDNEY-TRANSPLANT-WITH-HEMODIALYSIS-WITHOUT-MCC

    Kidney Transplant with Hemodialysis without MCC: Inpatient Reimbursement Overview

    652-KIDNEY-TRANSPLANT

    Kidney Transplant: Inpatient Reimbursement Overview

    653-MAJOR-BLADDER-PROCEDURES-WITH-MCC

    Major Bladder Procedures with MCC: Inpatient Reimbursement Overview

    654-MAJOR-BLADDER-PROCEDURES-WITH-CC

    Major Bladder Procedures with CC: Inpatient Reimbursement Overview

    655-MAJOR-BLADDER-PROCEDURES-WITHOUT-CC-MCC

    Major Bladder Procedures without CC/MCC: Inpatient Reimbursement Overview

    656-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITH-MCC

    Kidney and Ureter Procedures for Neoplasm with MCC: Inpatient Reimbursement Overview

    657-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITH-CC

    Kidney and Ureter Procedures for Neoplasm with CC: Inpatient Reimbursement Overview

    658-KIDNEY-AND-URETER-PROCEDURES-FOR-NEOPLASM-WITHOUT-CC-MCC

    Kidney and Ureter Procedures for Neoplasm without CC/MCC: Inpatient Reimbursement Overview

    659-KIDNEY-AND-URETER-PROCEDURES-FOR-NON-NEOPLASM-WITH-MCC

    Kidney and Ureter Procedures for Non-Neoplasm with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 41

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.